Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TeesuVac Breast Biopsy Device Mark 1

K-Number: K212079 · 2022-02-02

ApplicantTeesuvac Aps
Decision Date2022-02-02
Product CodeKNW
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

TeesuVac Breast Biopsy Device Mark 1 is the device name listed in this FDA 510(k) record. The listed applicant is Teesuvac Aps. It received FDA 510(k) clearance on 2022-02-02 under 510(k) number K212079. The device is classified under product code KNW. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TeesuVac Breast Biopsy Device Mark 1?

TeesuVac Breast Biopsy Device Mark 1 is a medical device that received FDA 510(k) clearance on 2022-02-02. The listed applicant is Teesuvac Aps. The 510(k) number is K212079.

When did TeesuVac Breast Biopsy Device Mark 1 receive FDA 510(k) clearance?

TeesuVac Breast Biopsy Device Mark 1 received FDA 510(k) clearance on 2022-02-02, under 510(k) number K212079.

Who is the listed applicant for TeesuVac Breast Biopsy Device Mark 1?

The FDA 510(k) record lists Teesuvac Aps as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for TeesuVac Breast Biopsy Device Mark 1?

The FDA product code for TeesuVac Breast Biopsy Device Mark 1 is KNW.

Related Devices (Code: KNW)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.